Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Tharimmune, Inc. - Common Stock
(NQ:
THAR
)
2.860
-0.100 (-3.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Tharimmune, Inc. - Common Stock
< Previous
1
2
3
4
Next >
Tharimmune Announces Initiation of Phase 1 Clinical Trial of TH104 and Provides Business Update
January 29, 2024
Via
ACCESSWIRE
12 Health Care Stocks Moving In Thursday's After-Market Session
January 25, 2024
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
January 24, 2024
Via
Benzinga
Perspective Therapeutics And 3 Other Stocks Under $1 Insiders Are Buying
December 19, 2023
The Dow Jones index closed slightly higher on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Tharimmune Announces Positive Topline Data with TH104, its Lead Candidate for Moderate-to-Severe Pruritus in Chronic Liver Disease Patients
December 11, 2023
Via
ACCESSWIRE
Why Is Liver Disease Focused Tharimmune Stock Trading Higher Today?
November 27, 2023
Tharimmune Inc (NASDAQ: THAR) released phase 1 data with TH104, a proprietary
Via
Benzinga
Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
December 08, 2023
Shares of Hello Group Inc. (NASDAQ: MOMO) jumped in pre-market trading after reporting results for the third quarter.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
December 07, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
December 04, 2023
Via
Benzinga
Tharimmune, Inc. Announces Closing of $11 Million Public Offering
November 30, 2023
Via
ACCESSWIRE
Stonegate Healthcare Partners Releases Report on Transformative Therapies for Pruritus Management
November 30, 2023
Dallas, Texas--(Newsfile Corp. - November 30, 2023) - Stonegate Healthcare Partners is pleased to...
Via
Newsfile
BioMedNewsBreaks – Tharimmune Inc. (NASDAQ: THAR) Announces Pricing of $10M Public Offering
November 29, 2023
Via
Investor Brand Network
Crude Oil Surges 2%; Tharimmune Shares Plummet
November 28, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining around 100 points on Tuesday. The Dow traded up 0.27% to 35,429.20 while the NASDAQ rose 0.12% to 14,258.32. The...
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why SenesTech Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 28, 2023
Shares of SenesTech, Inc. (NASDAQ: SNES) shares moved lower during Tuesday’s session after the company reported pricing of $5.0 million public offering.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
November 28, 2023
Via
Benzinga
Why Tharimmune Stock (THAR) Is Down 70% Today
November 28, 2023
Tharimmune Inc (NASDAQ: THAR) shares are trading lower by 71% to $1.00 Tuesday morning after the company priced an underwritten public offering of 10 million shares of common stock or pre-funded...
Via
Benzinga
Shein IPO Alert: 7 Things for Potential Shein Stock Investors to Know
November 28, 2023
Shein is in the news Tuesday as reports spread that the fast fashion company is preparing for an IPO that could take place in 2024.
Via
InvestorPlace
Topics
Initial Public Offering
Exposures
Securities Market
US Stocks Mixed; House Prices Rise In September
November 28, 2023
U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 10 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.04% to 35,345.85 while the NASDAQ fell...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Is SenesTech (SNES) Stock Down 36% Today?
November 28, 2023
SenesTech stock is falling on Tuesday after the company announced an offering for 3,846,154 shares of SNES at $1.30 per share.
Via
InvestorPlace
Why Is Tharimmune (THAR) Stock Down 70% Today?
November 28, 2023
Tharimmune stock is falling on Tuesday after the clinical-stage biotechnology company announced a public offering for THAR shares.
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 28, 2023
Via
Benzinga
Why SpringWorks Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
November 28, 2023
Shares of SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) surged in pre-market trading after the company reported the FDA approval of OGSIVEO (nirogacestat) as the first and only treatment for adults...
Via
Benzinga
Exposures
Product Safety
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
November 28, 2023
It's time to dive into the biggest pre-market stock movers for Tuesday morning with all of the latest news you need to know today!
Via
InvestorPlace
Tharimmune, Inc. Announces Pricing of $10 Million Public Offering
November 27, 2023
Via
ACCESSWIRE
12 Health Care Stocks Moving In Monday's After-Market Session
November 27, 2023
Via
Benzinga
Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
November 27, 2023
Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results.
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
November 27, 2023
Via
Benzinga
US Stocks Lower; Dow Falls Over 50 Points
November 27, 2023
U.S. stocks traded lower this morning, with the Dow Jones index falling over 50 points on Monday. Following the market opening Monday, the Dow traded down 0.18% to 35,328.05 while the NASDAQ fell 0.13%...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 27, 2023
Via
Benzinga
Tharimmune Reports Positive Phase 1 Data on TH104, its Lead Therapeutic Candidate, for Chronic Pruritis in Primary Biliary Cholangitis (PBC)
November 27, 2023
Via
ACCESSWIRE
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.